Your browser doesn't support javascript.
loading
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.
Bandara, Nilantha; Stott Reynolds, Tamila J; Schehr, Rebecca; Bandari, Rajendra P; Diebolder, Philipp J; Krieger, Stephanie; Xu, Jingli; Miao, Yubin; Rogers, Buck E; Smith, Charles J.
Afiliação
  • Bandara N; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, United States.
  • Stott Reynolds TJ; Research Division, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, 65201, United States; Department of Veterinary Pathobiology, Comparative Medicine Program, University of Missouri College of Veterinary Medicine, Columbia, MO 65211, United States.
  • Schehr R; Veterinary Research Scholars Program, University of Missouri College of Veterinary Medicine, Columbia, MO 65211, United States.
  • Bandari RP; Department of Radiology, University of Missouri School of Medicine, Columbia, MO 65211, United States.
  • Diebolder PJ; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, United States.
  • Krieger S; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, United States.
  • Xu J; Department of Radiology, School of Medicine, University of Colorado Denver Aurora, CO 80045, United States.
  • Miao Y; Department of Radiology, School of Medicine, University of Colorado Denver Aurora, CO 80045, United States.
  • Rogers BE; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, United States. Electronic address: b.rogers@wustl.edu.
  • Smith CJ; Research Division, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, 65201, United States; Department of Radiology, University of Missouri School of Medicine, Columbia, MO 65211, United States; University of Missouri Research Reactor Center, University of Missouri, Columbia, MO 65211, Unite
Nucl Med Biol ; 62-63: 71-77, 2018.
Article em En | MEDLINE | ID: mdl-29929115
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias da Próstata / Radioisótopos de Ítrio / Bombesina Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Nucl Med Biol Assunto da revista: BIOLOGIA / MEDICINA NUCLEAR Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias da Próstata / Radioisótopos de Ítrio / Bombesina Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Nucl Med Biol Assunto da revista: BIOLOGIA / MEDICINA NUCLEAR Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos